151 related articles for article (PubMed ID: 3873867)
21. Electrophysiological action of bepridil on atrioventricular accessory pathways.
Touboul P; Atallah G; Kirkorian G; Lavaud P; Kieny JR; Mathieu MP; Dellinger A
Br Heart J; 1987 Oct; 58(4):333-8. PubMed ID: 3499924
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil].
Fauchier JP; Cosnay P; Néel C; Rouesnel P; Bonnet P; Quilliet L
Arch Mal Coeur Vaiss; 1985 Apr; 78(4):612-9. PubMed ID: 3923987
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiologic effects of bepridil in the anesthetized dog studied by endocardiac electrodes.
Sassine A; Masse C; Fajuri A; Hirsch JL; Labrid C; Puech P
Am J Cardiol; 1984 Jun; 53(11):1707-11. PubMed ID: 6610347
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the anatomical tachycardia circuit in verapamil-sensitive atrial tachycardia originating from the vicinity of the atrioventricular node.
Yamabe H; Tanaka Y; Morihisa K; Uemura T; Enomoto K; Kawano H; Ogawa H
Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):54-62. PubMed ID: 19966013
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of verapamil-induced conduction block in anomalous atrioventricular bypass tracts.
Tai DY; Chang MS; Svinarich JT; Chiang BN; Sung RJ
J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):311-7. PubMed ID: 3968316
[TBL] [Abstract][Full Text] [Related]
26. Ethmozin. II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia.
Chazov EI; Rosenshtraukh LV; Shugushev KK
Am Heart J; 1984 Sep; 108(3 Pt 1):483-9. PubMed ID: 6382989
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
[TBL] [Abstract][Full Text] [Related]
28. A shared pathway in atrioventricular nodal reentrant tachycardia and atrial flutter: implications for pathophysiology and therapy.
Interian A; Cox MM; Jimenez RA; Duran A; Levin E; Garcia O; Cooper DK; Castellanos A; Myerburg RJ
Am J Cardiol; 1993 Feb; 71(4):297-303. PubMed ID: 8427171
[TBL] [Abstract][Full Text] [Related]
29. Effects of oral verapamil in patients with atrioventricular reentrant tachycardia incorporating an accessory pathway.
Wu D; Kou HC; Yeh SJ; Lin FC; Hung JS
Circulation; 1983 Feb; 67(2):426-33. PubMed ID: 6848233
[TBL] [Abstract][Full Text] [Related]
30. Electrophysiologic and antiarrhythmic effects of carocainide in humans.
Bach P; Steinbeck G
J Cardiovasc Pharmacol; 1988 Dec; 12(6):637-42. PubMed ID: 2467080
[TBL] [Abstract][Full Text] [Related]
31. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
[TBL] [Abstract][Full Text] [Related]
32. Effects of diltiazem, verapamil, and inhalation anesthetics on electrophysiologic properties affecting reentrant supraventricular tachycardia in chronically instrumented dogs.
Atlee JL; Bosnjak ZJ; Yeager TS
Anesthesiology; 1990 May; 72(5):889-901. PubMed ID: 2339803
[TBL] [Abstract][Full Text] [Related]
33. Fast-slow type of atrioventricular nodal reentrant tachycardia: horizontal dissociation of the AV node during tachycardia.
Fujiki A; Yoshida S; Mizumaki K; Sasayama S
Pacing Clin Electrophysiol; 1988 Nov; 11(11 Pt 1):1559-65. PubMed ID: 2462240
[TBL] [Abstract][Full Text] [Related]
34. Role of intravenous isoproterenol in the electrophysiologic induction of atrioventricular node reentrant tachycardia in patients with dual atrioventricular node pathways.
Huycke EC; Lai WT; Nguyen NX; Keung EC; Sung RJ
Am J Cardiol; 1989 Nov; 64(18):1131-7. PubMed ID: 2479251
[TBL] [Abstract][Full Text] [Related]
35. The relationship between refractory period and conduction time of the AV node under various cycle lengths in the canine heart. The significance of wavelength and excitable gap in reentrant tachycardia.
Segawa K
Jpn Heart J; 1996 May; 37(3):373-82. PubMed ID: 8774630
[TBL] [Abstract][Full Text] [Related]
36. Intravenous flecainide acetate for supraventricular tachycardias.
Hellestrand KJ
Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
[TBL] [Abstract][Full Text] [Related]
37. Effect of nifedipine and AQ-A 39 on the sinoatrial and atrioventricular nodes of the rabbit and their antiarrhythmic action on atrioventricular nodal reentrant tachycardia.
Senges J; Rizos I; Brachmann J; Anders G; Jauernig R; Hamman HD; Kübler W
Cardiovasc Res; 1983 Mar; 17(3):132-44. PubMed ID: 6871903
[TBL] [Abstract][Full Text] [Related]
38. Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias.
Hiejima K; Suzuki F; Takahashi M; Satake S
Jpn Circ J; 1983 Jan; 47(1):98-104. PubMed ID: 6827776
[TBL] [Abstract][Full Text] [Related]
39. Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds.
Hellestrand KJ; Nathan AW; Bexton RS; Camm AJ
Am J Cardiol; 1984 Feb; 53(5):30B-38B. PubMed ID: 6695817
[TBL] [Abstract][Full Text] [Related]
40. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
Pfitzner P; Manz M; Schütz R; Lüderitz B
Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
